HPV: Clinical Trials

105 trials for HPV, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

39 completed, 35 recruiting, 10 unknown, 7 active not recruiting. 50 Not applicable, 11 Phase 2, 8 Phase 4, 3 Phase 1, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable50Recruiting 20, Completed 14, Not yet recruiting 6, Active not recruiting 5, Terminated 2, Unknown 2, Suspended 1
Phase 211Completed 4, Recruiting 3, Active not recruiting 1, Not yet recruiting 1, Unknown 1, Withdrawn 1
Phase 48Completed 4, Recruiting 3, Terminated 1
Phase 13Completed 2, Active not recruiting 1
Early Phase 11Recruiting 1
Phase 31Unknown 1

Follow HPV: new trials by email Literature Review of HPV trials Research Report on HPV

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
My Self-Sampling for HPV Awareness, Results, and Empowerment
MySHARE+ mHealth Education Intervention, Healthcare Provider Prompt - Cervical Cancer, Cervical Cancer Screening
Not applicableNot yet recruitingDaisy Le1302027-01-012026-08-18
Effect of Web-Based Education on Attitudes and Beliefs About HPV Testing
Web-Based Health Education - Cervical Cancer, HPV
Not applicableNot yet recruitingSakarya University1202026-11-012026-09-22
Feasibility Study Comparing One vs Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive Women Living With HIV in C1001P-CS7 Zimbabwe
Thermal ablation (TA) with 1 probe, Thermal ablation (TA) with 2 probes - HIV (Human Immunodeficiency Virus), HPV
Not applicableRecruitingFred Hutchinson Cancer Center3002026-10-152026-10-19
Feasibility Study Comparing One vs Two Probes for TA Among Cervical Cancer Screen Positive WLWH in C1001P-CS5 Rwanda
Thermal ablation (TA) with 1 probe, Thermal ablation (TA) with 2 probes - HIV (Human Immunodeficiency Virus), HPV
Not applicableRecruitingFred Hutchinson Cancer Center3002026-10-152026-10-19
Feasibility Study Comparing One vs Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive WLWH in C1001P-CS9 South Africa
Thermal ablation (TA) with 1 probe, Thermal ablation (TA) with 2 probes - HIV (Human Immunodeficiency Virus), HPV
Not applicableRecruitingFred Hutchinson Cancer Center2002026-10-152026-10-20
Feasibility Study Comparing Use of One Or Two Probes for Thermal Ablation Among Screen Positive Women Living With HIV in C1001P-CS2 Kenya
Thermal ablation (TA) with 1 probe, Thermal ablation (TA) with 2 probes - HIV (Human Immunodeficiency Virus), HPV
Not applicableRecruitingFred Hutchinson Cancer Center3002026-10-122026-10-20
Prognostic Biomarkers for Patients With Human Papillomavirus (HPV) Positive Oropharyngeal Squamous Cell Carcinoma
MRI - Oropharyngeal Squamous Cell Carcinoma (OPSCC), HPV
Not applicableNot yet recruitingAbramson Cancer Center at Penn Medicine302026-09-152026-09-01
Addressing HPV Vaccine Hesitancy by Co-Designing a Digital Health Intervention
HPV-Kompassen - HPV, Vaccine Acceptance
Not applicableNot yet recruitingKarolinska Institutet1002026-08-012026-06-08
National Rapid TLC: Testing and Linkage to Care
Xpert® HIV-1 Qual XC - HIV, Chlamydia
Not applicableNot yet recruitingUnity Health Toronto25002026-08-012026-07-28
Comparative Self-collection for Cervical Cancer Screening Pivotal Study
Mia by XytoTest, Rovers Cervex-Brush - HPV, HPV - Anogenital Human Papilloma Virus Infection
Not applicableRecruitingMel Mont Medical2602026-07-092026-08-11
Digital Interventions to Increase HPV Vaccination Intentions Among Nigerian Caregivers
Chatbot counseling, Misinformation-resistance pre-bunking inoculation, Short edutainment - HPV, HPV Vaccine
Not applicableRecruitingUniversity of Pennsylvania33402026-05-072026-07-16
A Bio-Psycho-Social Medical Model-Based Study on Adolescent Female HPV Vaccination Behavior and Comprehensive Intervention
the BPS-based comprehensive intervention - HPV, Vaccination Hesitancy
Not applicableNot yet recruitingThe Children's Hospital of Zhejiang University School of Medicine3002026-04-302026-05-01
Impact of Internal Menstrual Protections on Immunity and Vaginal Microbiota
Samples collection (whole blood, urine, vaginal and cervical cells) - Sexual Transmitted Disease, Vaginosis, Bacterial
RecruitingCentre National de la Recherche Scientifique, France3002026-04-072026-04-09
A Clinical Trial to Investigate the Safety and Efficacy of Papillex® on Abnormal Cervical Cells Caused by HPV.
Papillex®, Placebo - CIN - Cervical Intraepithelial Neoplasia, CIN 1
Not applicableRecruitingPapillex Inc.602026-03-012026-07-08
Emergency Department-based Cervical Cancer Screening Through Self-sampling
Cervical Cancer Screening - HPV, HPV Associated Cancers
Not applicableRecruitingUniversity of Rochester2002026-02-132026-05-04
Study Assessing Reduced HPV Infectivity and Transmission in HPV-Positive Women Following Vaccination With 9vHPV
Nonavalent HPV vaccine (9vHPV) - HPV, High-risk HPV (Any Strain)
Phase 2Not yet recruitingInstitut d'Investigació Biomèdica de Bellvitge802026-02-012026-02-11
HPV After chemoRadioTherapy
Cervical Cancer Recurrent, Radiotherapy
RecruitingGeneral University Hospital, Prague1202026-02-012026-03-25
Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer
Q-Pad hrHPV Test System - HPV Infection, HPV 16 Infection
Not applicableRecruitingQurasense4502025-12-012026-07-24
Playing Game to Learn About Children's Vaccine Project
vaccination game - HPV, Vaccine-Preventable Diseases
Not applicableRecruitingMichigan State University1802025-10-272026-05-20
PopSci CHW4CervixHealth
Evalyn® Brush, Copan Floqswab, CHW4CervicalHealth - Cervical Cancer, Hpv
Not applicableRecruitingThomas Jefferson University1202025-10-222026-08-11

Showing 20 of 105. Sign in to see all of them.

Narrower conditions

Uterine Cervical Neoplasms (28)  ·  Papillomavirus Infections (16)  ·  Uterine Cervical Dysplasia (9)  ·  Acquired Immunodeficiency Syndrome (7)  ·  Anus Neoplasms (5)  ·  Oropharyngeal Neoplasms (5)  ·  Neoplasms (4)  ·  Head and Neck Neoplasms (3)  ·  Homosexuality (3)  ·  Sexually Transmitted Diseases (3)  ·  Squamous Cell Carcinoma of Head and Neck (3)  ·  Warts (3)  ·  HIV Infections (2)  ·  Multiple Endocrine Neoplasia Type 1 (2)  ·  Social Stigma (2)

Broader conditions

Genital Diseases (49)  ·  Urogenital Diseases (49)  ·  Neoplasms (45)  ·  Neoplasms by Site (41)  ·  Female Urogenital Diseases (36)  ·  Female Urogenital Diseases and Pregnancy Complications (36)  ·  Genital Diseases, Female (36)  ·  Uterine Cervical Diseases (35)  ·  Uterine Diseases (35)  ·  Infections (30)  ·  Genital Neoplasms, Female (28)  ·  Urogenital Neoplasms (28)  ·  Uterine Neoplasms (28)  ·  Communicable Diseases (27)  ·  Virus Diseases (25)

Interventions

Carboplatin (3)  ·  Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 (3)  ·  Papillomavirus Vaccines (3)  ·  Colposcopy (2)  ·  Focus Groups (2)  ·  Interviews as Topic (2)  ·  Paclitaxel (2)  ·  Radiation (2)  ·  Vaccination (2)  ·  Aging (1)  ·  Cetuximab (1)  ·  Chemoradiotherapy (1)  ·  Cisplatin (1)  ·  Costs and Cost Analysis (1)  ·  Fluorouracil (1)

Sponsors

Fred Hutchinson Cancer Center (4)  ·  National Cancer Institute (NCI) (4)  ·  University of Rochester (3)  ·  Duke University (2)  ·  Emory University (2)  ·  Falu Hospital (2)  ·  General University Hospital, Prague (2)  ·  M.D. Anderson Cancer Center (2)  ·  Memorial Sloan Kettering Cancer Center (2)  ·  Milton S. Hershey Medical Center (2)  ·  Monash University (2)  ·  Unity Health Toronto (2)  ·  University of British Columbia (2)  ·  University of Chicago (2)  ·  Washington University School of Medicine (2)

Countries

United States (43)  ·  Canada (5)  ·  France (4)  ·  Italy (4)  ·  Turkey (Türkiye) (4)  ·  China (3)  ·  Kenya (3)  ·  Nigeria (3)  ·  Australia (2)  ·  Czechia (2)  ·  Denmark (2)  ·  Germany (2)  ·  South Africa (2)  ·  Sweden (2)  ·  Tanzania (2)

Top investigators

Leeya Pinder, MD, MPH (4)  ·  Margaret M Madeleine, PhD, MPH (4)  ·  Rachel L Winer, PhD, MPH (4)  ·  Hanna I Sahlgren, md (2)  ·  Jennifer Moss, PhD (2)  ·  Acharf Shamseddine, MD (1)  ·  Allison Kempe, MD, MPH (1)  ·  Ann Chang, MD (1)  ·  Anna-Barbara Moscicki, MD (1)  ·  Anne De Groot, MD (1)  ·  Antje Blank, Dr. (1)  ·  Ari Rosenberg, MD (1)  ·  Betty Chou, MD (1)

Results publications

PMID 38516651, PMID 16333078, PMID 20885156, PMID 22914406, PMID 23878179, PMID 24771940, PMID 25299412, PMID 26980480, PMID 27230391, PMID 28626767, PMID 29507681, PMID 30281807, PMID 31792083, PMID 33417628, PMID 33683424, PMID 34167543, PMID 34914727, PMID 34954217, PMID 36446560, PMID 36823557, PMID 37389484, PMID 38285445, PMID 38476208, PMID 39715483, PMID 39717960, PMID 40215795, PMID 40312377, PMID 40394508, PMID 40674748, PMID 40833975, PMID 42818472

NIH funding

U24CA275417 (4), UG1CA275402 (4), 2023 (2), 2017 (1), 5UG1CA284671-03 (1), 5UG1CA284918-03 (1), R01CA210125 (1), R01CA240649 (1), R01CA270276 (1), R01CA271033 (1), R01CA279973 (1), R01TW012415 (1), R37CA234030 (1), U54CA153513 (1), U54CA163068 (1)